These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

316 related items for PubMed ID: 6154076

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Cell-mediated immunity to antigens associated with murine sarcoma virus-induced tumors: augmentation of cytolytic T lymphocyte activity by successive specific and nonspecific stimulation in vitro.
    Ryser JE, Cerottini JC, Brunner KT.
    Eur J Immunol; 1979 Mar; 9(3):179-84. PubMed ID: 221224
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Alloantigen-induced cytotoxicity against syngeneic tumor cells: analysis at the clonal level.
    Sensi M, Orosz CG, Bach FH.
    J Immunol; 1984 Jun; 132(6):3218-25. PubMed ID: 6202778
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Secondary in vitro generation of cytolytic T-lymphocytes (CTL's) in the murine sarcoma virus system. Virus-specific CTL induction across the H-2 barrier.
    Collavo D, Parenti A, Biasi G, Chieco-Bianchi L, Colombatti A.
    J Natl Cancer Inst; 1978 Sep; 61(3):885-90. PubMed ID: 80457
    [Abstract] [Full Text] [Related]

  • 10. Primary and secondary in vitro generation of cytolytic T lymphocytes in the murine sarcoma virus system.
    Plata F, Cerottini JC, Brunner KT.
    Eur J Immunol; 1975 Apr; 5(4):227-33. PubMed ID: 185057
    [Abstract] [Full Text] [Related]

  • 11. Requirements for T cells in alloantigen-induced generation of non-T cell-mediated cytotoxicity against syngeneic mouse sarcoma cells.
    Paciucci PA, Macphail S, Bach FH, Zarling JM.
    J Immunol; 1980 Jul; 125(1):36-9. PubMed ID: 6155401
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. T cell-mediated immunity to oncornavirus-induced tumors. I. Ly phenotype of precursor and effector cytolytic T lymphocytes.
    Leclerc JC, Cantor H.
    J Immunol; 1980 Feb; 124(2):846-50. PubMed ID: 6243332
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Inhibition of cytolytic T lymphocyte clones reactive with Moloney leukemia virus-associated antigens by monoclonal antibodies: a direct approach to the study of H-2 restriction.
    Weiss A, MacDonald HR, Cerottini JC, Brunner KT.
    J Immunol; 1981 Feb; 126(2):482-5. PubMed ID: 6450244
    [Abstract] [Full Text] [Related]

  • 17. Monoclonal antibody against IFN-gamma inhibits Moloney murine sarcoma virus-specific cytotoxic T lymphocyte differentiation.
    Zanovello P, Vallerani E, Biasi G, Landolfo S, Collavo D.
    J Immunol; 1988 Feb 15; 140(4):1341-4. PubMed ID: 2830339
    [Abstract] [Full Text] [Related]

  • 18. Functional activity in vivo of effector T cell populations. II. Anti-tumor activity exhibited by syngeneic anti-MoMULV-specific cytolytic T cell clones.
    Engers HD, Lahaye T, Sorenson GD, Glasebrook AL, Horvath C, Brunner KT.
    J Immunol; 1984 Sep 15; 133(3):1664-70. PubMed ID: 6205090
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.